Clinical trial
Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
NCT00005816 · Duke University, Other · Completed
Key facts
| NCT number | NCT00005816 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer |
| Official title | Active Immunotherapy of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA |
| Lead sponsor | Duke University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Procedure |
| Interventions | therapeutic autologous dendritic cells, conventional surgery |
| Enrollment | 15 |
| Start date | Feb 1, 2000 |
| Completion | Aug 1, 2002 |
| First posted | Mar 23, 2004 |
| Last update posted | Mar 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: